Impax Receives Final FDA Approval for Generic Depakote Tablets

Impax Laboratories, Inc. confirmed that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Application (ANDA) for generic version of Depakote (divalproex ER) 250mg Extended-release Tablets.
MSN